Stock Scorecard
Stock Summary for Co-Diagnostics Inc (CODX) - $0.34 as of 5/9/2025 9:04:57 PM EST
Total Score
12 out of 30
Safety Score
21 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CODX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CODX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CODX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CODX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CODX (21 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 10 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 3 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CODX
Financial Details for CODX
Company Overview |
|
|---|---|
| Ticker | CODX |
| Company Name | Co-Diagnostics Inc |
| Country | USA |
| Description | Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 0.34 |
| Price 4 Years Ago | 8.93 |
| Last Day Price Updated | 5/9/2025 9:04:57 PM EST |
| Last Day Volume | 68,546 |
| Average Daily Volume | 146,130 |
| 52-Week High | 2.23 |
| 52-Week Low | 0.28 |
| Last Price to 52 Week Low | 21.43% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 48.91 |
| Sector PE | 47.92 |
| 5-Year Average PE | 0.02 |
| Free Cash Flow Ratio | 3.78 |
| Industry Free Cash Flow Ratio | 39.21 |
| Sector Free Cash Flow Ratio | 30.82 |
| Current Ratio Most Recent Quarter | 4.41 |
| Total Cash Per Share | 0.09 |
| Book Value Per Share Most Recent Quarter | 1.64 |
| Price to Book Ratio | 0.22 |
| Industry Price to Book Ratio | 5.21 |
| Sector Price to Book Ratio | 27.83 |
| Price to Sales Ratio Twelve Trailing Months | 3.02 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.47 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 33,572,600 |
| Market Capitalization | 11,414,684 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 30.80% |
| Annual Earnings Growth | -6.53% |
| Reported EPS 12 Trailing Months | -1.24 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -1.15 |
| Net Income Twelve Trailing Months | -37,639,008 |
| Net Income Past Year | -37,639,008 |
| Net Income Prior Year | -35,332,865 |
| Quarterly Revenue Growth YOY | -95.80% |
| 5-Year Revenue Growth | 78.68% |
| Operating Margin Twelve Trailing Months | -7,974.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,936,544 |
| Total Cash Past Year | 2,936,544 |
| Total Cash Prior Year | 14,916,878 |
| Net Cash Position Most Recent Quarter | 2,936,544 |
| Net Cash Position Past Year | 2,936,544 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 54,311,918 |
| Total Stockholder Equity Prior Year | 86,013,615 |
| Total Stockholder Equity Most Recent Quarter | 54,311,918 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -29,903,397 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.89 |
| Free Cash Flow Past Year | -29,903,397 |
| Free Cash Flow Prior Year | -23,447,171 |
Options |
|
| Put/Call Ratio | 1.61 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.01 |
| MACD Signal | -0.02 |
| 20-Day Bollinger Lower Band | 0.18 |
| 20-Day Bollinger Middle Band | 0.56 |
| 20-Day Bollinger Upper Band | 0.94 |
| Beta | 0.84 |
| RSI | 44.11 |
| 50-Day SMA | 1.76 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 3.24 |
System |
|
| Modified | 5/9/2025 9:05:44 PM EST |